Recent News
Novartis Says Gilenya Benefits Outweigh Risks, Despite FDA Warning
Despite concerns that Gilenya might cause worsening MS symptoms when treatment stops, Novartis continues to back its blockbuster medication. In an email to BioPharma Drive, a spokesperson for the drug company noted that the multiple sclerosis medication had been used … Continue reading
Spinal-Cord Stimulator Implants Mean Big Bucks for Device Makers. But What About Patients?
Medtronic, Inc. and other medical device makers are reaping huge financial rewards from spinal-cord stimulator implant systems designed to treat chronic pain disorders. However, a new investigation conducted by the Associated Press and other media outlets throughout the world found … Continue reading
Proton Pump Inhibitors May Increase Risk for C Difficile Infection in Children
A new study is pointing to yet another potentially serious side effects related to proton pump inhibitors, a class of heart burn medications that includes Nexium, Prilosec, and PrevAcid. The findings, which were recently published in the Journal of Microbiology, … Continue reading
Valsartan Lawsuit Alleges Recalled Blood Pressure Drug Caused Deadly Kidney Cancer
Generic valsartan manufacturers face mounting lawsuits in courts throughout the United States, following a massive, global recall for contaminated heart and blood pressure drugs. One of the most recent cases involves a Louisiana man diagnosed with kidney cancer in November … Continue reading
First Benzocaine and Homeopathic Teething Tablets, Now Honey Pacifiers are Hurting Babies.
As though benzocaine oral painkillers and homeopathic teething tablets weren’t enough, parents are now being warned not to give their cranky babies honey pacifiers. Apparently, the soothers have been implicated in 4 cases of infant botulism that recently occurred in Texas. Honey … Continue reading
Onglyza Lawsuit Alleges “Concerted Effort” to Conceal Heart Failure Risk
Onglyza lawsuits continue to mount in the multidistrict litigation now underway in the U.S. District Court, Eastern District of Kentucky, where a recent filing claims AstraZeneca and other Defendants engaged in a concerted effort to conceal the relationship between saxagliptin … Continue reading
FDA Won’t Ban Flavored E-Cigarettes, Even as it Looks to Restrict Teen Use
Despite reports to the contrary, the U.S. Food & Drug Administration (FDA) will not ban retail stores from selling fruit- and dessert-flavored e-cigarettes cartridges popular among teenagers. Rather, the agency will try to force convenience stores, gas stations, and other … Continue reading
European Union Close to Restricting Fluoroquinolone Antibiotics
The European Medicines Agency (EMA) has endorsed tough restrictions on fluoroquinolone antibiotics, amid concerns that the drugs can cause nerve damage, tendon ruptures, and other potentially permanent side effects. The move comes as hundreds of plaintiffs continue to pursue personal … Continue reading
Federal Taxotere Lawsuits Move Forward, With Additional Bellwether Trial Nominations
Taxotere lawsuits are moving forward in the U.S. District Court, Eastern District of Louisiana, where preparations continue for upcoming trials. Federal Taxotere Litigation to Convene 6 Bellwether Trials According to an Order dated November 8th, the Court now intends to … Continue reading
Monsanto Roundup Lawsuit Trial Moved to March, as Glyphosate Cancer Claims Mount
A California judge has agreed to expedite the state’s second trial involving Monsanto’s popular Roundup weed killer, due to concerns over the plaintiffs’ health. Elderly Couple Blames Regular Roundup Use for Their Cancer Diagnoses According to a complaint filed on … Continue reading
Follow Us
